Sort by
Refine Your Search
-
Listed
-
Program
-
Employer
-
Field
-
. The research focus of our group is on parallel computing, supercomputing, and performance tuning and optimization of advanced applications. Our team currently consists of 10 scientific and 3 administrative
-
for large samples at ESRF ID16A using multislice tomography approaches. You will lead the development of and work with parallelized computer models to simulate how coherent waves travel through materials with
-
, 6GIC was officially launched with parallel research undertaken in both 5G+ and 6G for 2030+. About you The post holder must have: Strong research and analytical skills. Track record of publications in
-
information sciences. In parallel with basic research, we develop ideas and technologies further into innovations and services. We are experts in systems science; we develop integrated solutions from care
-
key industrial partners. In November 2020, 6GIC was officially launched with parallel research undertaken in both 5G+ and 6G for 2030+. About you The post holder must have: Strong research and
-
, and a solid understanding of numerical analysis and familiarity with the use of analytical tools. They should also have knowledge and experience in parallel coding and spectral methods. They must have
-
permeability selection in variant membrane chemistries. This work will run in parallel to experimental analysis conducted at the University of Exeter using synthetic vesicles to observe permeability
-
. The focus will be on a stage of disease when both confirmation of the diagnosis and measurement of therapeutic response remain challenging. You will be specifically involved in two parallel studies making use
-
and measurement of therapeutic response remain challenging. You will be specifically involved in two parallel studies making use of a portable, noninvasive muscle recording device in both home- and
-
cancer organoids from Black male patients. The project will seek to characterise the viability of organoids in response to standard of care chemotherapy and novel agents. In parallel the project will seek